Pancreatic Cancer Research

ResearcherWakayama Medical UniversityActive in the last 2 years

Shogo Ehata

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6740-9391; OpenAlex author ID A5056598242. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. In vitro functional analysis of lysyl oxidase family members in highly metastatic pancreatic cancer cells derived from a syngeneic orthotopic model. Last author DOI 10.1186/s12885-026-16173-1↗
  2. Neurotensin receptor 1 signaling promotes pancreatic cancer progression. First author DOI 10.1002/1878-0261.12815↗
  3. Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells. First author DOI 10.1038/s41388-018-0144-0↗
  4. Smad4 Decreases the Population of Pancreatic Cancer-Initiating Cells through Transcriptional Repression of ALDH1A1. Last author DOI 10.1016/j.ajpath.2015.01.011↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kohei Miyazono · 4 shared papers, 2015–2026 · strength 0.59
  2. Kei Takahashi · 3 shared papers, 2018–2026 · strength 0.54
  3. Manabu Kawai · 1 shared paper, 2026 · strength 0.29
  4. Yukari Hoshino · 1 shared paper, 2015 · strength 0.05
  5. Taku Aoki · 1 shared paper, 2015 · strength 0.05
  6. Norihiro Kokudo · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.